This week there are a handful of venture, mezzanine and alternative investment associate positions up for grabs as well as a senior position as director of institutional alternative investments at UBS Financial Services.

European powerhouse CVC Capital Partners takes the crown in this week’s battle of the U.S. and European mega-buyout houses, securing first place in our list of top 10 funds based on private equity performance figures from California State Teachers’ Retirement System. U.S. and European firms both account for five of the top-10 spots with The Blackstone Group coming in a close second place.

Last week, we discovered which private equity firm was the biggest dealmaker. Now it’s time for the largest PE deals of the year. Global PE-backed M&A totaled $267 billion so far in 2012, a 12% drop from 2011, according to preliminary data from Thomson Reuters. Private equity-backed mergers targeting the U.S. reached roughly $137 billion year-to-date, a 7% decline from 2011.

BC Partners and CPP Investment Board have completed the previously announced purchase of the Cequel Communications Holdings for $6.6 billion. Cequel Communications does business as Suddenlink Communications.

Euro-denominated buyout funds, which play a prominent role in CPP Investment Board’s portfolio, have provided some solid returns over the years. But there is one player that shines above the rest, according to the Buyouts performance database.

BC Partners, CPP Investment Board and management are to acquire Cequel Communications, which does business as Suddenlink Communications, for $6.6 billion. Suddenlink is a cable system operator in the US offering television, high-speed Internet and telephony services to over 1.4 million residential and commercial customers, primarily in Texas, West Virginia, North Carolina, Oklahoma, Arkansas and [...]

CPPIB continues to diversify into Asia and Latin America and India, but is also still very much focused on Europe. The proof is in the private equity pudding with CPPIB making its largest 2011 vintage commitment to a European buyout behemouth.

Dendreon Corporation has agreed to sell for $125 million in cash its royalty interest related to intellectual property licensed to Schering and associated with VICTRELIS, a treatment for chronic hepatitis C. The royalty interest was acquired by CPPIB Credit Investments, a wholly-owned subsidiary of CPP Investment Board. PRESS RELEASE Dendreon Corporation today announced that it [...]